Similar articles

• [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors].

  Niibe H, Takahashi I, Mitsuhashi N, Miyaishi K, Itoh J, Maehara Y, Nakajima N, Suto H, Sakaino K, Matsuura S, et al. Niibe H, et al. Nihon Gan Chiryo Gakkai Shi. 1985 Jun 20;20(5):984-93. Nihon Gan Chiryo Gakkai Shi. 1985. PMID: 2997351 Clinical Trial. Japanese. No abstract available.
• [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 2. Abdominal and pelvic tumors].

  Niibe H, Takahashi I, Miyaishi K, Mitsuhashi N, Maehara Y, Nakajima N, Suto H, Saito Y, Yamakawa M, Sugiyama S, et al. Niibe H, et al. Nihon Gan Chiryo Gakkai Shi. 1985 Jun 20;20(5):994-1001. Nihon Gan Chiryo Gakkai Shi. 1985. PMID: 2997352 Clinical Trial. Japanese. No abstract available.
• [Radioprotective effect of YM-08310 in radiotherapy of cervical cancer].

  Takahashi M, Abe M, Kawamura T, Iio A, Hamamoto K, Inohara T. Takahashi M, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):435-42. Nihon Igaku Hoshasen Gakkai Zasshi. 1982. PMID: 6294593 Japanese. No abstract available.
• Studies on radioprotectors in mammals and their possible use in radiotherapy--a summary.

  Kumar S. Kumar S. Radiobiol Radiother (Berl). 1985;26(3):359-65. Radiobiol Radiother (Berl). 1985. PMID: 2997830 Review. No abstract available.
• Can WR-2721 be improved upon?

  Brown DQ, Graham WJ 3rd, MacKenzie LJ, Pittock JW 3rd, Shaw LM. Brown DQ, et al. Pharmacol Ther. 1988;39(1-3):157-68. doi: 10.1016/0163-7258(88)90057-5. Pharmacol Ther. 1988. PMID: 2849121 Review. No abstract available.